Fresenius Kabi Pharma Portugal, Lda. secures contract for Cetorolac 30 Mg/1 Ml Sol Inj Fr 1 Ml Im Iv

Portugal, Feb. 2 -- Portugal based Fresenius Kabi Pharma Portugal, Lda. has secured contract from Unidade Local De Saude De Almada-Seixal, Epe for Cetorolac 30 Mg/1 Ml Sol Inj Fr 1 Ml Im Iv. The value of the contract is worth 225000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....